REGEN4HD
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Phase 1/2 study testing an investigational treatment to assess its safety and tolerability in people with Huntington's disease.
RecruitingPhase 1 / Phase 2BiologicalClinicalTrials.govTreatment trial
Recruiting in: Irvine, United States
Sponsor: Leslie Thompson
Preparing a short plain-English summary.